Effect of intravenous ferric carboxymaltose on hemoglobin response among patients with acute isovolemic anemia following gastrectomy the FAIRY randomized clinical trial

JAMA - Journal of the American Medical Association

Volumn 317, Issue 20, 2017, Pages 2097-2104

  Kim, Young Woo ^a,b   Bae, Jae Moon ^c   Park, Young Kyu ^d   Yang, Han Kwang ^e   Yu, Wansik ^f   Yook, Jeong Hwan ^g   Noh, Sung Hoon ^h   Han, Mira ^b   Ryu, Keun Won ^b   Sohn, Tae Sung ^c   Lee, Hyuk Joon ^e   Kwon, Oh Kyoung ^f   Ryu, Seung Yeob ^d   Lee, Jun Ho ^c   Kim, Sung ^c   Yoon, Hong Man ^b   Eom, Bang Wool ^b   Choi, Min Gew ^c   Kim, Beom Su ^g   Jeong, Oh ^d   Suh, Yun Suhk ^e   Yoo, Moon Won ^g   Lee, In Seob ^g   Jung, Mi Ran ^d   An, Ji Yeong ^c   Kim, Hyoung Il ^h   Kim, Youngsook ^b   Yang, Hannah ^b   Nam, Byung Ho ^b   more..

^a National Cancer Center   (South Korea)

^b National Cancer Center   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Chonnam National University   (South Korea)

^e Seoul National University   (South Korea)

^f Kyungpook National University School of Medicine   (South Korea)

^g University of Ulsan College of Medicine   (South Korea)

^h Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FERRIC CARBOXYMALTOSE; FERRITIN; HEMOGLOBIN; IRON; PLACEBO; SODIUM CHLORIDE; TRANSFERRIN; ANTIANEMIC AGENT; FERRIC ION; MALTOSE;

ACUTE ISOVOLEMIC ANEMIA; ADJUVANT THERAPY; ADULT; ANAPHYLAXIS; ANEMIA; ARTICLE; CLINICAL OUTCOME; CONSTIPATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; FERRITIN BLOOD LEVEL; FEVER; GASTRECTOMY; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; INJECTION SITE REACTION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PHLEBITIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; SOUTH KOREA; STOMACH CANCER; TRANSFERRIN BLOOD LEVEL; TREATMENT DURATION; TREATMENT RESPONSE; URTICARIA; ADVERSE EFFECTS; AGED; ANALOGS AND DERIVATIVES; BLOOD; CLINICAL TRIAL; INJECTION; METABOLISM; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SINGLE BLIND PROCEDURE;

ADULT; AGED; ANEMIA; FEMALE; FERRIC COMPOUNDS; GASTRECTOMY; HEMATINICS; HEMOGLOBINS; HUMANS; INJECTIONS; MALE; MALTOSE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SINGLE-BLIND METHOD;

EID: 85019589701     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.5703     Document Type: Article

References (21)

1. Gombotz H, Rehak PH, Shander A, Hofmann A. Blood use in elective surgery: The Austrian benchmark study. Transfusion. 2007;47(8):1468- 1480.
2. Shander A, Knight K, Thurer R, Adamson J, Spence R. Prevalence and outcomes of anemia in surgery: A systematic review of the literature. Am J Med. 2004;116(suppl 7A):58S-69S.
3. Weiskopf RB, Kramer JH, Viele M, et al. Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology. 2000;92(6):1646-1652.
4. Weiskopf RB, Feiner J, Hopf HW, et al. Oxygen reverses deficits of cognitive function and memory and increased heart rate induced by acute severe isovolemic anemia. Anesthesiology. 2002;96(4): 871-877.
5. Lim CH, Kim SW, KimWC, et al. Anemia after gastrectomy for early gastric cancer: Long-term follow-up observational study. World J Gastroenterol. 2012;18(42):6114-6119.
6. Yoon HM, Kim YW, Nam BH, et al. Intravenous iron supplementation may be superior to observation in acute isovolemic anemia after gastrectomy for cancer. World J Gastroenterol. 2014;20(7):1852-1857.
7. Park SH, Nam E, Bang SM, Cho EK, Shin DB, Lee JH. A randomized trial of anemia correction with two different hemoglobin targets in the first-line chemotherapy of advanced gastric cancer. Cancer Chemother Pharmacol. 2008;62(1):1-9.
8. Adachi Y, Mimori K, Mori M, Maehara Y, Sugimachi K. Morbidity after D2 and D3 gastrectomy for node-positive gastric carcinoma. J AmColl Surg. 1997;184(3):240-244.
9. Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med. 2008;358(12):1229-1239.
10. Weber RS, Jabbour N, Martin RC II. Anemia and transfusions in patients undergoing surgery for cancer. Ann Surg Oncol. 2008;15(1):34-45.
11. HyungWJ, Noh SH, Shin DW, et al. Adverse effects of perioperative transfusion on patients with stage III and IV gastric cancer. Ann Surg Oncol. 2002;9(1):5-12.
12. Keating GM. Ferric carboxymaltose: A review of its use in iron deficiency. Drugs. 2015;75(1):101-127.
13. Reim D, Kim YW, Nam BH, et al. FAIRY: A randomized controlled patient-blind phase III study to compare the efficacy and safety of intravenous ferric carboxymaltose (Ferinject) to placebo in patients with acute isovolemic anemia after gastrectomy-study protocol for a randomized controlled trial. Trials. 2014;15:111.
14. Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Somerfield MR, Temin S. American society of clinical oncology/American society of hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Oncol Pract. 2010;6(6):317-320.
15. Carson JL, Noveck H, Berlin JA, Gould SA. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion. 2002;42(7):812-818.
16. Evstatiev R, Marteau P, Iqbal T, et al; FERGI Study Group. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology. 2011;141(3):846-853.e1, 2.
17. Fayers P, Bottomley A; EORTC Quality of Life Group; Quality of Life Unit; European Organisation for Research and Treatment of Cancer. Quality of life research within the EORTC-the EORTC QLQ-C30. Eur J Cancer. 2002;38(suppl 4):S125-S133.
18. US Food and Drug Administration. Center for Drug Evaluation and Research: Application number 203565Orig1s000: Medical Review(s). https://www.accessdata.fda.gov/drugsatfda-docs/nda/2013/203565Orig1s000MedR.pdf. Accessed April 19, 2017.
19. Schafer JL. Multiple imputation: A primer. Stat Methods Med Res. 1999;8(1):3-15.
20. Bregman DB, Goodnough LT. Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemia. Ther Adv Hematol. 2014;5 (2):48-60.
21. Macdougall IC, Bock AH, Carrera F, et al; FIND-CKD Study Investigators. FIND-CKD: A randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia. Nephrol Dial Transplant. 2014;29(11):2075-2084.